Form 8-K - Current report:
SEC Accession No. 0001140361-25-019156
Filing Date
2025-05-15
Accepted
2025-05-15 09:16:08
Documents
15
Period of Report
2025-05-15
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ny20049047x1_8k.htm   iXBRL 8-K 47047
2 EXHIBIT 3.1 ny20049047x1_ex3-1.htm EX-3.1 30532
3 EXHIBIT 3.2 ny20049047x1_ex3-2.htm EX-3.2 123194
  Complete submission text file 0001140361-25-019156.txt   380276

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA allk-20250515.xsd EX-101.SCH 3979
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE allk-20250515_lab.xml EX-101.LAB 22691
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE allk-20250515_pre.xml EX-101.PRE 16550
18 EXTRACTED XBRL INSTANCE DOCUMENT ny20049047x1_8k_htm.xml XML 4375
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

EIN.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38582 | Film No.: 25949209
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)